International #NASHDay 2021 – another step towards making #NAFLD a global public health priority

June 9, 2021 3:34 pm Published by Leave your thoughts1 Comment% Comments

Alongside organisations around the globe, EILF is marking International #NASHDay on June 10. We have had a busy past 12 months since the last #NASHDay, here are a few highlights!

1. EIU collaboration in Asia, Latin America and the Middle East

We concluded our collaboration with the Economist Intelligence Unit in Asia Latin America and the Middle East. Check out our Twitter where we’ll be sharing clips from the report launch throughout the day.  You can also see the full report here. 

2. Wilton Park Dialogues

With Wilton Park, a global forum for strategic discussion, we bought together thought-leaders, healthcare providers, industry executives and high-level government decision-makers from 24 countries, covering all global regions. We also held a series of roundtable discussions on how to design comprehensive models of care for NAFLD and NASH. Explore the Wilton Park report here. 

4. NAFLD Consensus Statement

In early 2021 we started work on the NAFLD Consueus Statement, bringing together over 200 experts from around the globe to agree on what actions are required to advance the NAFLD agenda. The consensus statement will be published in late 2021 and will provide a foundation for developing the NAFLD public health roadmap.

4. Fostering collaborations, new and old

Over the past years, EILF has collaborated with over 500 individuals and organisations. We thank everybody who has given their time, energy and expertise to support our goal of making NAFLD a public health priority.


Categorised in:

This post was written by Henry Mark

Message from the Chairman

February 11, 2017 9:59 pm Published by Leave your thoughts1 Comment% Comments

In the last decades, a series of impressive advancements in the care of deadly liver diseases have taken place in consequence of breakthrough discoveries that came through at an unprecedented pace with respect to previous years. Prevention and effective treatment of the lethal consequences of viral hepatitis, comprehension of the mechanisms causing metabolic liver diseases and life-saving treatments of liver cancer to name some, stand as illuminating examples of this success.

Instrumental to these achievements was the hard work of numerous teams of scientists  and clinicians actively engaged in the European Association for the Study of the Liver (EASL), a synergy that further helped EASL to grow in scientific reputation worldwide while strengthening its commitment to disseminate education in the care of liver patients and backing research programs in top laboratories across Europe.

However, while the clinical benefits of all these scientific achievements have been crystal clear to the vast arena of the hepatologists, this is not completely true for a majority of the liver patients, general practitioners and, generally speaking, for members of the global society. To fill this educational gap, EASL has established the International Liver Foundation which, in full synergy with EASL, has the mandate to foster educational programs on liver disease management outside the european borders, raise funds and liaise with other scientific institutions to power the research activity of european centres and increase awareness in the field of liver disease relying on both institutional and private resourches.

We believe that the Foundation will succeed in achieving these goals as it can rely on the strong commitment towards science and education of the members EASL and the generous support of all those who believe in the power of mankind.


Categorised in:

This post was written by SOTO Admin